What is Epilepsy?
Epilepsy is the fourth most common neurological disorder and affects people of all ages. Seizures are a common characteristic of epilepsy either predictable or unpredictable, and epilepsy often includes other health problems. One of the largest challenges facing people with epilepsy is the stigma and misunderstanding surrounding the disorder. If you would like to contribute to further research on epilepsy causes and treatments, please visit our donation page.
The epilepsy team at the HBI has strong links to the Alberta Children's Hospital Research Institute creating full-spectrum epilepsy treatment spanning all ages. The team comprises a variety of researchers from different faculties and departments. Meet the team
Living with Epilepsy
Nicole Janssen is CEO of Alta ML, a massively successful Edmonton based AI company, a mother and wife, a horse-back rider and advocate for epilepsy awareness. Nicole was first diagnosed with epilepsy in 2019, and faced the challenge of discovering what that diagnosis meant for her.
Derek Payne is an active member of Calgary’s community, having held various CFO and VP roles for companies like DIRTT and Westjet. He is currently an advisor to multiple initiatives and companies working in epilepsy, as well as a dedicated father and husband, and cross-fit coach!
Derek was first diagnosed with epilepsy in 1999, and had brain surgery in 2015.
Epilepsy can be a very isolating disorder, but it doesn't have to be. Support and understanding are vital - sharing lived experience is the first step to breaking the stigma.
Dr. Morris Scantlebury’s research is focused on a ketogenic diet as a potential treatment for infantile spasms. These studies are supported by the community through the Alberta Children’s Hospital Foundation, and HBI. Read more about this treatment here.
Laser Interstitial Thermal Therapy (LITT) combines robotics, magnetic resonance imagery and laser-directed heat to burn off brain tumours. Read more about the usage of this treatment here.
Dr. Deborah Kurrasch is exploring new models for epilepsy treatment, including the benefits and limitations of zebrafish modelling in discovering new antiseizure drug treatments. Read the full publication here.